Advertisement
Advertisement

TAOX

TAOX logo

Tao Synergies Inc. Common Stock

6.48
USD
Sponsored
+0.32
+5.19%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

6.45

-0.04
-0.54%

Tao Synergies Inc. Common Stock Profile

About

Synaptogenix Inc. is an emerging biopharmaceutical company. It focused on developing therapies for neurodegenerative diseases. The company's lead therapeutic candidate consist Bryostatin-1. Synaptogenix Inc. is based in NEW YORK.

Info & Links

CEO

Joshua N. Silverman

Headquarters

1185 Avenue of the Americas, 3rd Floor
New York, NY 10036, UNITED STATES

Industry

Financial Miscellaneous Services

Sector

Finance

Website

www.taosynergies.com

Auditor

Stephano Slack LLC

Share holders

299

Employees

5

Tao Synergies Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

48.16M

Enterprise Value

42.66M

Enterprise Value/EBITDA(ttm)

-4.72

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.78

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-111661.58%

Return on Equity(ttm)

-193.08%

Return on Invested Capital(ttm)

-196.92%

Return on Assets(ttm)

-144.93%

Income Statement

Revenue(ttm)

299.10K

Revenue Per Share(ttm)

0.04

Gross Profit(ttm)

299.10K

EBITDA(ttm)3

-9.04M

Net Income Available to Common(ttm)

-29.08M

Diluted EPS(ttm)

-17.14

Share Statistics

Beta (5Y Monthly)

1.68

52-Week Change

--

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

7.47M

Dividend Yield

0.00%

Float4

7.27M

% Held by Insiders

2.70%

% Held by Institutions

10.34%

Balance Sheet

Total Cash(mrq)

5.50M

Total Cash Per Share(mrq)

0.74

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

17.61%

Quick Ratio(mrq)

13.99%

Book Value Per Share(mrq)

3.68

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.55

Free Cash Flow(ytd)

-3.94M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement